These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
767 related articles for article (PubMed ID: 30995930)
1. Discriminative validity of the EQ-5D-5 L and SF-12 in older adults with arthritis. Tawiah AK; Al Sayah F; Ohinmaa A; Johnson JA Health Qual Life Outcomes; 2019 Apr; 17(1):68. PubMed ID: 30995930 [TBL] [Abstract][Full Text] [Related]
2. A comparison of utility measurement using EQ-5D and SF-6D preference-based generic instruments in patients with rheumatoid arthritis. Salaffi F; Carotti M; Ciapetti A; Gasparini S; Grassi W Clin Exp Rheumatol; 2011; 29(4):661-71. PubMed ID: 21813061 [TBL] [Abstract][Full Text] [Related]
3. Comparative performance of the EQ-5D-5L and SF-6D index scores in adults with type 2 diabetes. Sayah FA; Qiu W; Xie F; Johnson JA Qual Life Res; 2017 Aug; 26(8):2057-2066. PubMed ID: 28364183 [TBL] [Abstract][Full Text] [Related]
4. Estimating the burden of disease in chronic pain with and without neuropathic characteristics: does the choice between the EQ-5D and SF-6D matter? Torrance N; Lawson KD; Afolabi E; Bennett MI; Serpell MG; Dunn KM; Smith BH Pain; 2014 Oct; 155(10):1996-2004. PubMed ID: 25020004 [TBL] [Abstract][Full Text] [Related]
5. Comparison of the preference-based EQ-5D-5L and SF-6D in patients with end-stage renal disease (ESRD). Yang F; Lau T; Lee E; Vathsala A; Chia KS; Luo N Eur J Health Econ; 2015 Dec; 16(9):1019-26. PubMed ID: 25519850 [TBL] [Abstract][Full Text] [Related]
6. An empirical evaluation of the SF-12, SF-6D, EQ-5D and Michigan Hand Outcome Questionnaire in patients with rheumatoid arthritis of the hand. Dritsaki M; Petrou S; Williams M; Lamb SE Health Qual Life Outcomes; 2017 Jan; 15(1):20. PubMed ID: 28118833 [TBL] [Abstract][Full Text] [Related]
7. Validity and responsiveness of EuroQol-5 dimension (EQ-5D) versus Short Form-6 dimension (SF-6D) questionnaire in chronic pain. Obradovic M; Lal A; Liedgens H Health Qual Life Outcomes; 2013 Jul; 11():110. PubMed ID: 23815777 [TBL] [Abstract][Full Text] [Related]
8. Quality of Life and General Health After Elective Surgery for Cervical Spine Pathologies: Determining a Valid and Responsive Metric of Health State Utility. Chotai S; Parker SL; Sivaganesan A; Godil SS; McGirt MJ; Devin CJ Neurosurgery; 2015 Oct; 77(4):553-60; discussion 560. PubMed ID: 26191977 [TBL] [Abstract][Full Text] [Related]
9. Comparison of EQ-5D and SF-6D utilities in Pompe disease. Kanters TA; Redekop WK; Kruijshaar ME; van der Ploeg AT; Rutten-van Mölken MP; Hakkaart L Qual Life Res; 2015 Apr; 24(4):837-44. PubMed ID: 25342117 [TBL] [Abstract][Full Text] [Related]
10. EQ-5D-5L and SF-6D Utility Measures in Symptomatic benign Thyroid Nodules: Acceptability and Psychometric Evaluation. Wong CKH; Lang BHH; Yu HMS; Lam CLK Patient; 2017 Aug; 10(4):447-454. PubMed ID: 28224296 [TBL] [Abstract][Full Text] [Related]
11. Comparison of the EQ-5D and SF-12 health surveys in a general population survey in Alberta, Canada. Johnson JA; Pickard AS Med Care; 2000 Jan; 38(1):115-21. PubMed ID: 10630726 [TBL] [Abstract][Full Text] [Related]
12. Validity of EQ-5D-5L health-related quality of life questionnaire in self-reported diabetes: evidence from a general population survey. Jankowska A; Młyńczak K; Golicki D Health Qual Life Outcomes; 2021 May; 19(1):138. PubMed ID: 33952271 [TBL] [Abstract][Full Text] [Related]
13. The relationship between body mass index and health-related quality of life: comparing the EQ-5D, EuroQol VAS and SF-6D. Sach TH; Barton GR; Doherty M; Muir KR; Jenkinson C; Avery AJ Int J Obes (Lond); 2007 Jan; 31(1):189-96. PubMed ID: 16682976 [TBL] [Abstract][Full Text] [Related]
14. Assessing the empirical validity of alternative multi-attribute utility measures in the maternity context. Petrou S; Morrell J; Spiby H Health Qual Life Outcomes; 2009 May; 7():40. PubMed ID: 19419553 [TBL] [Abstract][Full Text] [Related]
15. A head-to-head comparison of EQ-5D-5L and SF-6D in Dutch patients with fractures visiting a Fracture Liaison Service. Li N; Boonen A; van den Bergh JP; van Kuijk SMJ; Wyers CE; van Oostwaard M; Vranken L; Bours SPG; Hiligsmann M J Med Econ; 2022; 25(1):829-839. PubMed ID: 35674412 [TBL] [Abstract][Full Text] [Related]
16. Differential Psychometric Properties of EuroQoL 5-Dimension 5-Level and Short-Form 6-Dimension Utility Measures in Low Back Pain. Cheung PWH; Wong CKH; Cheung JPY Spine (Phila Pa 1976); 2019 Jun; 44(11):E679-E686. PubMed ID: 30475342 [TBL] [Abstract][Full Text] [Related]
17. A comparison between the EQ-5D and the SF-6D in patients with chronic obstructive pulmonary disease (COPD). Chen J; Wong CK; McGhee SM; Pang PK; Yu WC PLoS One; 2014; 9(11):e112389. PubMed ID: 25379673 [TBL] [Abstract][Full Text] [Related]
18. Validation and comparison of EuroQoL-5 dimension (EQ-5D) and Short Form-6 dimension (SF-6D) among stable angina patients. Wu J; Han Y; Zhao FL; Zhou J; Chen Z; Sun H Health Qual Life Outcomes; 2014 Oct; 12():156. PubMed ID: 25343944 [TBL] [Abstract][Full Text] [Related]
19. Psychometric properties of the EuroQol-5D and Short Form-6D in patients with systemic lupus erythematosus. Aggarwal R; Wilke CT; Pickard AS; Vats V; Mikolaitis R; Fogg L; Block JA; Jolly M J Rheumatol; 2009 Jun; 36(6):1209-16. PubMed ID: 19369452 [TBL] [Abstract][Full Text] [Related]
20. Interchangeability of the EQ-5D and the SF-6D, and comparison of their psychometric properties in a spinal postoperative Spanish population. Selva-Sevilla C; Ferrara P; Gerónimo-Pardo M Eur J Health Econ; 2020 Jun; 21(4):649-662. PubMed ID: 32065301 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]